At a glance
ClinicalIndex Comparison RecordN/ACompleted· 15,628 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Reduced Estimated Glomerular Filtration Rate (eGFR)and Prediction of Cardiovascular Disease and Renal Outcome in Subjects With Type 2 Diabetes: Italian Multicenter Study
In Brief
An observational study for Cardiovascular Disease. Completed, enrolled 15,628 participants across 20 sites.
Detailed Summary
Reduced glomerular filtration rate (GFR) has been recently shown to be a powerful predictor of cardiovascular morbidity and mortality in the general population, independent of traditional cardiovascular risk factors. This observational study is aimed at assessing the association of reduced estimated GFR with cardiovascular morbidity and mortality in a large italian population (at least 15,000 subjects) of type 2 diabetic outpatients over a 4-year follow-up.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Disease
CountriesItaly
CollaboratorsItalian Society of Diabetology
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJun 2008
First PostedJul 2008
Primary CompletionNov 2008
Study CompletionFeb 2015
TodayJul 2026
First PostedJul 15, 2008
Enrollment StartJun 1, 2008
Primary CompletionNov 1, 2008
Study CompletionFeb 1, 2015
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 18.0 years ago